International speakers include:

  • Dr Nick Loman
    Bioinformatics Research Associate, Division of Immunity and Infection
    University of Birmingham
  • Dr Joris Veltman
    Department of Human Genetics
    Radboud University Nijmegen Medical Centre
  • Dr Peter Verhasselt
    Sequencing Expert
    Johnson & Johnson
  • Roderic Guigó
    Senior Group Leader, Genomic Regulations, Biomedical Informatics
    IMIM-Hospital del Mar, Spain
  • Dr Nicholas H. Bergman
    Principal Investigator and Genomics Team Leader
    National Biodefense Analysis and Countermeasures Center, USA
  • Dr Bhupinder Bhullar
    Lab Head, Developmental & Molecular Pathways
    Novartis Institute for Biomedical Research
  • Dr Harma Feitsma
    Research Scientist Molecular Diagnostics
    Philips Research Labs

Pursue deep genetic information for progressive disease research and medical R&D by utilising the right genotyping tools and accurate data analysis

The January London Pharma IQ Next-Generation DNA Sequencing conference has been organised to explore the applications of next generation sequencers for whole genome sequencing, de novo sequencing and human disease diagnosis and prediction.

Case studies from academia and biopharma will compare current sequencers with existing microarray and other genotyping analysis tools, assessing current technology based on sensitivity, reliability, reproducibility, cost and time to results.

Join your colleagues to discuss how to choose the right technology for your research projects and accurately scan and identify rare variants in genes, short sequence repeats and mutations early on. Learn how to:

  • Reduce error margins by comparing key performance criteria and applications of today’s next-generation sequencing systems
  • Predict disease risk at genome level by using next-generation systems to accurately scan and identify rare variants in genes, short sequence repeats and CNPs
  • Answer scientific questions and identify compound-target mechanisms by evaluating the right next generation approach: Deep vs. wide, de novo vs. re-sequencing
  • Cope with vast amounts of sequencing data and overcome data archiving issues such as metadata complexity, data volumes and network bandwidth

Don’t miss the Interactive Peer-to-Peer Workshop Discussions

  • Workshop A: Managing Data Volume and Data Complexity from Next-Generation Sequencing
  • Workshop B: Comparing High-Throughput Gene Analysis Systems: Conventional Microarray Technology vs. NGS Systems

Who will you meet?

Share implementation stories with your colleagues on how they are attaining much greater detail of gene activity and finding mutations earlier with lower level screens.

Attend to meet professionals from academia, research institutes, biopharma industry and technology and service providers including Directors, Managers, Heads of and Principal Scientists from:

  • Molecular Biology
  • Discovery / Basic Research
  • Genetics Research / Genome Sciences
  • Bioinformatics /Computation Biology
  • Pharamcogenomics
  • DNA Sequencing or Genotyping Technology
  • Clinical Biomarkers /Clinical Diagnosis

Testimonials

Next generation sequencing technology will undoubtedly change the medical field by giving us the genomic information needed for accurate diagnosis and personalized medicine. I look forward to discussing the implementation of this technology with world leaders in the field this January in London.
Dr Joris Veltman, Radboud University Nijmegen Medical Centre
This meeting, amongst users of the technology, is important to learn the solutions to the problems in the applications of next-gen technology and really helps me develop our internal processes
Dr Bhupinder Bhullar, Novartis Pharma AG
Gold Exhibitors Session Sponsors
Animated sponsors session sponsors
Featured Exhibitor Media Partners
gatc Animated media

[ Register Now ]